Bruce V Taylor
Bruce V Taylor
menzies Research Institute Tasmania University of Tasmania
Verified email at
Cited by
Cited by
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis
Nature 476 (7359), 214-219, 2011
Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations.
JZ Liu
Nature genetics 47 (9), 979-986, 2015
Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis.
X Montalban
New England Journal of Medicine, 2017
Atlas of multiple sclerosis 2013: a growing global problem with widespread inequity
P Browne, D Chandraratna, C Angood, H Tremlett, C Baker, BV Taylor, ...
Neurology 83 (11), 1022-1024, 2014
Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis
International IBD Genetics Consortium (IIBDGC), C Agliardi, L Alfredsson, ...
Nature genetics 45 (11), 1353-1360, 2013
Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci
PL De Jager, X Jia, J Wang, PIW De Bakker, L Ottoboni, NT Aggarwal, ...
Nature genetics 41 (7), 776-782, 2009
Latitude is significantly associated with the prevalence of multiple sclerosis: a meta-analysis
S Simpson, L Blizzard, P Otahal, I Van der Mei, B Taylor
Journal of Neurology, Neurosurgery & Psychiatry 82 (10), 1132-1141, 2011
Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility
International Multiple Sclerosis Genetics Consortium*†, ANZgene, ...
Science 365 (6460), eaav7188, 2019
Past exposure to sun, skin phenotype, and risk of multiple sclerosis: case-control study
IAF van der Mei, AL Ponsonby, T Dwyer, L Blizzard, R Simmons, ...
Bmj 327 (7410), 316, 2003
Higher 25‐hydroxyvitamin D is associated with lower relapse risk in multiple sclerosis
S Simpson Jr, B Taylor, L Blizzard, AL Ponsonby, F Pittas, H Tremlett, ...
Annals of neurology 68 (2), 193-203, 2010
The fine-scale genetic structure of the British population.
s Leslie
Nature 519 (7543), 2015
Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20
Data analysis: Bahlo Melanie 2 Brown Matthew A 6 7 Browning Brian L 20 ...
Nature genetics 41 (7), 824-828, 2009
Oral fingolimod in primary progressive multiple sclerosis (INFORMS): a phase 3, randomised, double-blind, placebo-controlled trial.
F Lublin, D Miller
Lancet 387 (10023), 1075-84, 2016
Sun exposure and vitamin D are independent risk factors for CNS demyelination
RM Lucas, AL Ponsonby, K Dear, PC Valery, MP Pender, BV Taylor, ...
Neurology 76 (6), 540-548, 2011
Chronic inflammatory demyelinating polyradiculoneuropathy: from pathology to phenotype
EK Mathey, SB Park, RAC Hughes, JD Pollard, PJ Armati, MH Barnett, ...
Journal of Neurology, Neurosurgery & Psychiatry 86 (9), 973-985, 2015
Vitamin D levels in people with multiple sclerosis and community controls in Tasmania, Australia
IAF van der Mei, AL Ponsonby, T Dwyer, L Blizzard, BV Taylor, T Kilpatrick, ...
Journal of neurology 254, 581-590, 2007
Class II HLA interactions modulate genetic risk for multiple sclerosis.
L Moutsianas, L Jostins
Nature Genetics 47 (10), 1107-13, 2015
Prevalence and concurrence of anxiety, depression and fatigue over time in multiple sclerosis
B Wood, IAF Van Der Mei, AL Ponsonby, F Pittas, S Quinn, T Dwyer, ...
Multiple Sclerosis Journal 19 (2), 217-224, 2013
Fine-mapping the genetic association of the major histocompatibility complex in multiple sclerosis: HLA and non-HLA effects
NA Patsopoulos, LF Barcellos, RQ Hintzen, C Schaefer, CM Van Duijn, ...
PLoS genetics 9 (11), e1003926, 2013
Genome‐wide meta‐analysis identifies novel multiple sclerosis susceptibility loci
NA Patsopoulos, ...
Annals of neurology 70 (6), 897-912, 2011
The system can't perform the operation now. Try again later.
Articles 1–20